Global Antibiotics Market Opportunities and Forecast 2020-2027
- DLR2508
- 11 August, 2021
- Pharma & Healthcare
- Pages: 120
- Global
Global Antibiotics Market, By Drug Class (Aminoglycosides, Beta-Lactams [Penicillin, Carbapenems, Cephalosporin], Macrolides, Phenicols, Quinolones/Fluoroquinolones, Tetracycline, Sulfonamides, Others), By Route Of Administration (Oral, Topical, Sublingual, Inhalation, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and opportunities and forecast 2020-2027
Antibiotics Market Overview
Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply. The global Antibiotics market is mainly driven by the development of novel methods for new antibiotics for treating bacterial infections and a large number of clinical trials.
Furthermore, the rising incidence of infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are some important factors significantly boosting the growth of the global Antibiotics market. Additionally, growing investments in research and development by biotech companies are projected to enlarge the growth of the global Antibiotics market.
On the other hand, the development of antibiotic resistance and increase in drug approval costs are anticipated to hamper the growth of the market. Besides this, the discovery of advanced prospect molecules and the introduction of novel combination therapies to treat antibiotic-resistant microbial infections are anticipated to create lucrative opportunities for market players during the forecast period.
Covid-19 Impact on Antibiotics Market
In addition, the current Antibiotics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Antibiotics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Antibiotics Market Segment Overview
Based on Drug Class, the Beta-Lactams is the fastest-growing segment in the global Antibiotics market. Growth of the beta-lactams segment can be attributed to rapidly increasing antibacterial resistance, the need for a new broad spectrum of agents, and the need to control infection in health care settings. According to Distribution Channel, Online Pharmacies are the largest segment in the market. The growth of the online pharmacies segment can be mainly attributed to the focus of e-commerce companies on the pharmaceutical sector to deliver medication to customers at the doorstep and ease of buying medication online.
Antibiotics Market, By Drug Class
· Oral
· Topical
· Sublingual
· Inhalation
· Intravenous
Antibiotics Market, By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
Antibiotics Regional Overview
Region-wise, Asia Pacific commanded a major share, in terms of revenue of the global Antibiotics market. This is due to the increasing prevalence of various infectious diseases, favorable regulatory reforms, growing population & unhygienic conditions giving rise to antibiotic resistance bacteria, and significant demand for generic medicines. Likewise, North America and Europe are key regions for the Antibiotics market. Important factors such as well-developed healthcare infrastructure, the rising incidence of infectious diseases, and growing healthcare expenditure by the government are largely contributes to the development of the market in these regions.
Antibiotics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Antibiotics Market, Key Players
· AstraZeneca plc
· Bristol-Myers Squibb Co.
· Bayer HealthCare AG
· The Menarini Group
· GlaxoSmithKline plc
· Eli Lilly and Company
· Johnson & Johnson
· Merck & Co., Inc.
· Novartis AG
· Sanofi
· Teva Pharmaceutical Industries Ltd.
Antibiotics Market Overview
Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply. The global Antibiotics market is mainly driven by the development of novel methods for new antibiotics for treating bacterial infections and a large number of clinical trials.
Furthermore, the rising incidence of infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the current gap in the demand and supply of antibiotics are some important factors significantly boosting the growth of the global Antibiotics market. Additionally, growing investments in research and development by biotech companies are projected to enlarge the growth of the global Antibiotics market.
On the other hand, the development of antibiotic resistance and increase in drug approval costs are anticipated to hamper the growth of the market. Besides this, the discovery of advanced prospect molecules and the introduction of novel combination therapies to treat antibiotic-resistant microbial infections are anticipated to create lucrative opportunities for market players during the forecast period.
Covid-19 Impact on Antibiotics Market
In addition, the current Antibiotics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Antibiotics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Antibiotics Market Segment Overview
Based on Drug Class, the Beta-Lactams is the fastest-growing segment in the global Antibiotics market. Growth of the beta-lactams segment can be attributed to rapidly increasing antibacterial resistance, the need for a new broad spectrum of agents, and the need to control infection in health care settings. According to Distribution Channel, Online Pharmacies are the largest segment in the market. The growth of the online pharmacies segment can be mainly attributed to the focus of e-commerce companies on the pharmaceutical sector to deliver medication to customers at the doorstep and ease of buying medication online.
Antibiotics Market, By Drug Class
- Aminoglycosides
- Beta-Lactams
- Penicillin
- Carbapenems
- Cephalosporin
- Macrolides
- Phenicols
- Quinolones/Fluoroquinolones
- Tetracycline
- Sulfonamides
- Others
· Oral
· Topical
· Sublingual
· Inhalation
· Intravenous
Antibiotics Market, By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
Antibiotics Regional Overview
Region-wise, Asia Pacific commanded a major share, in terms of revenue of the global Antibiotics market. This is due to the increasing prevalence of various infectious diseases, favorable regulatory reforms, growing population & unhygienic conditions giving rise to antibiotic resistance bacteria, and significant demand for generic medicines. Likewise, North America and Europe are key regions for the Antibiotics market. Important factors such as well-developed healthcare infrastructure, the rising incidence of infectious diseases, and growing healthcare expenditure by the government are largely contributes to the development of the market in these regions.
Antibiotics Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Antibiotics Market, Key Players
· AstraZeneca plc
· Bristol-Myers Squibb Co.
· Bayer HealthCare AG
· The Menarini Group
· GlaxoSmithKline plc
· Eli Lilly and Company
· Johnson & Johnson
· Merck & Co., Inc.
· Novartis AG
· Sanofi
· Teva Pharmaceutical Industries Ltd.
Antibiotics Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Drug Class
- 5.2.1. Aminoglycosides
- 5.2.2. Beta-Lactams
- 5.2.2.1. Penicillin
- 5.2.2.2. Carbapenems
- 5.2.2.3. Cephalosporin
- 5.2.3. Macrolides
- 5.2.4. Phenicols
- 5.2.5. Quinolones/Fluoroquinolones
- 5.2.6. Tetracycline
- 5.2.7. Sulfonamides
- 5.2.8. Others
- 5.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 5.3.1. Oral
- 5.3.2. Topical
- 5.3.3. Sublingual
- 5.3.4. Inhalation
- 5.3.5. Intravenous
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Online Pharmacies
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Drug Class
- 6.2.1. Aminoglycosides
- 6.2.2. Beta-Lactams
- 6.2.2.1. Penicillin
- 6.2.2.2. Carbapenems
- 6.2.2.3. Cephalosporin
- 6.2.3. Macrolides
- 6.2.4. Phenicols
- 6.2.5. Quinolones/Fluoroquinolones
- 6.2.6. Tetracycline
- 6.2.7. Sulfonamides
- 6.2.8. Others
- 6.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 6.3.1. Oral
- 6.3.2. Topical
- 6.3.3. Sublingual
- 6.3.4. Inhalation
- 6.3.5. Intravenous
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hospital Pharmacies
- 6.4.2. Retail Pharmacies
- 6.4.3. Online Pharmacies
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Drug Class
- 7.2.1. Aminoglycosides
- 7.2.2. Beta-Lactams
- 7.2.2.1. Penicillin
- 7.2.2.2. Carbapenems
- 7.2.2.3. Cephalosporin
- 7.2.3. Macrolides
- 7.2.4. Phenicols
- 7.2.5. Quinolones/Fluoroquinolones
- 7.2.6. Tetracycline
- 7.2.7. Sulfonamides
- 7.2.8. Others
- 7.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 7.3.1. Oral
- 7.3.2. Topical
- 7.3.3. Sublingual
- 7.3.4. Inhalation
- 7.3.5. Intravenous
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Drug Class
- 8.2.1. Aminoglycosides
- 8.2.2. Beta-Lactams
- 8.2.2.1. Penicillin
- 8.2.2.2. Carbapenems
- 8.2.2.3. Cephalosporin
- 8.2.3. Macrolides
- 8.2.4. Phenicols
- 8.2.5. Quinolones/Fluoroquinolones
- 8.2.6. Tetracycline
- 8.2.7. Sulfonamides
- 8.2.8. Others
- 8.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 8.3.1. Oral
- 8.3.2. Topical
- 8.3.3. Sublingual
- 8.3.4. Inhalation
- 8.3.5. Intravenous
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hospital Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Online Pharmacies
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Antibiotics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Drug Class
- 9.2.1. Aminoglycosides
- 9.2.2. Beta-Lactams
- 9.2.2.1. Penicillin
- 9.2.2.2. Carbapenems
- 9.2.2.3. Cephalosporin
- 9.2.3. Macrolides
- 9.2.4. Phenicols
- 9.2.5. Quinolones/Fluoroquinolones
- 9.2.6. Tetracycline
- 9.2.7. Sulfonamides
- 9.2.8. Others
- 9.3. Market Analysis, Insights and Forecast – By Route Of Administration
- 9.3.1. Oral
- 9.3.2. Topical
- 9.3.3. Sublingual
- 9.3.4. Inhalation
- 9.3.5. Intravenous
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hospital Pharmacies
- 9.4.2. Retail Pharmacies
- 9.4.3. Online Pharmacies
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. AstraZeneca plc
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Bristol-Myers Squibb Co.
- 10.6. Bayer HealthCare AG
- 10.7. The Menarini Group
- 10.8. GlaxoSmithKline plc
- 10.9. Eli Lilly and Company
- 10.10. Johnson & Johnson
- 10.11. Merck & Co., Inc.
- 10.12. Novartis AG
- 10.13. Sanofi
List of Figures
Figure 1: Global Antibiotics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Antibiotics Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Antibiotics Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Antibiotics Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Antibiotics Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Antibiotics Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Antibiotics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Antibiotics Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Antibiotics Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Antibiotics Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Antibiotics Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Antibiotics Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Antibiotics Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Antibiotics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Antibiotics Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Antibiotics Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Antibiotics Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Antibiotics Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Antibiotics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Antibiotics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Antibiotics Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Antibiotics Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Antibiotics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Figure 1: Global Antibiotics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Antibiotics Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Antibiotics Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Antibiotics Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Antibiotics Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Antibiotics Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Antibiotics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Antibiotics Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Antibiotics Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Antibiotics Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Antibiotics Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Antibiotics Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Antibiotics Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Antibiotics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Antibiotics Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Antibiotics Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Antibiotics Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Antibiotics Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Antibiotics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Antibiotics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Antibiotics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Antibiotics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Antibiotics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Antibiotics Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Antibiotics Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Antibiotics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Antibiotics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Antibiotics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Report You Might be Interested
Choose License Type
- USD
- GBP
- EURO
- INR
